NDC 43353-305

ULORIC

Febuxostat

ULORIC is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Febuxostat.

Product ID43353-305_196bf4ca-b625-424a-8c4f-6be167d2bd2e
NDC43353-305
Product TypeHuman Prescription Drug
Proprietary NameULORIC
Generic NameFebuxostat
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-02-13
Marketing CategoryNDA / NDA
Application NumberNDA021856
Labeler NameAphena Pharma Solutions - Tennessee, LLC
Substance NameFEBUXOSTAT
Active Ingredient Strength40 mg/1
Pharm ClassesXanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 43353-305-60

90 TABLET in 1 BOTTLE (43353-305-60)
Marketing Start Date2017-04-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43353-305-60 [43353030560]

ULORIC TABLET
Marketing CategoryNDA
Application NumberNDA021856
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-04-07

Drug Details

Active Ingredients

IngredientStrength
FEBUXOSTAT40 mg/1

OpenFDA Data

SPL SET ID:24ac0ee2-cd7b-4dda-a1bb-271e32331758
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 834239
  • 834235
  • Pharmacological Class

    • Xanthine Oxidase Inhibitor [EPC]
    • Xanthine Oxidase Inhibitors [MoA]

    NDC Crossover Matching brand name "ULORIC" or generic name "Febuxostat"

    NDCBrand NameGeneric Name
    21695-516ULORICfebuxostat
    43353-305ULORICfebuxostat
    55154-5158ULORICfebuxostat
    55154-5159ULORICfebuxostat
    64764-677ULORICULORIC
    64764-918ULORICULORIC
    0054-0413FebuxostatFebuxostat
    0054-0414FebuxostatFebuxostat
    0378-3925Febuxostatfebuxostat
    0378-3926Febuxostatfebuxostat
    0527-2244FEBUXOSTATfebuxostat
    0527-2248FEBUXOSTATfebuxostat
    14445-156FebuxostatFebuxostat
    14445-157FebuxostatFebuxostat
    16714-059FebuxostatFebuxostat
    16714-060FebuxostatFebuxostat
    27808-206Febuxostatfebuxostat
    27808-207Febuxostatfebuxostat
    43547-295FEBUXOSTATfebuxostat
    43547-296FEBUXOSTATfebuxostat
    46708-190Febuxostatfebuxostat
    46708-191Febuxostatfebuxostat
    47335-721FebuxostatFebuxostat
    47335-722FebuxostatFebuxostat
    48792-7905FEBUXOSTATfebuxostat
    48792-7906FEBUXOSTATfebuxostat
    51407-293FebuxostatFebuxostat
    51407-294FebuxostatFebuxostat
    55111-796FebuxostatFebuxostat
    55111-797FebuxostatFebuxostat
    60687-538FebuxostatFebuxostat
    62332-190Febuxostatfebuxostat
    62332-191Febuxostatfebuxostat
    63304-864FebuxostatFebuxostat

    Trademark Results [ULORIC]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ULORIC
    ULORIC
    85060525 3916684 Live/Registered
    TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED)
    2010-06-11
    ULORIC
    ULORIC
    78108573 2739132 Live/Registered
    TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED)
    2002-02-13
    ULORIC
    ULORIC
    77671366 not registered Dead/Abandoned
    Takeda Pharmaceuticals North America, Inc.
    2009-02-16
    ULORIC
    ULORIC
    77671352 3800552 Live/Registered
    TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED)
    2009-02-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.